Trilayered tissue construct mimicking the orientations of three layers of a native heart valve leaflet.

Cell and Tissue Research
Soumen Jana, Amir Lerman

Abstract

A tissue-engineered heart valve can be an alternative to a prosthetic valve in heart valve replacement; however, it is not fully efficient in terms of long-lasting functionality, as leaflets in engineered valves do not possess the trilayered native leaflet structure. Previously, we developed a flat, trilayered, oriented nanofibrous (TN) scaffold mimicking the trilayered structure and orientation of native heart valve leaflets. In vivo tissue engineering-a practical regenerative medicine technology-can be used to develop an autologous heart valve. Thus, in this study, we used our flat, trilayered, oriented nanofibrous scaffolds to develop trilayered tissue structures with native leaflet orientations through in vivo tissue engineering in a rat model. After 2 months of in vivo tissue engineering, infiltrated cells and their deposited collagen fibrils were found aligned in the circumferential and radial layers, and randomly oriented in the random layer of the scaffolds, i.e., trilayered tissue constructs (TTCs) were developed. Tensile properties of the TTCs were higher than that of the control tissue constructs (without any scaffolds) due to influence of fibers of the scaffolds in tissue engineering. Different extracellular matrix ...Continue Reading

References

Nov 18, 2000·Circulation·S P HoerstrupJ E Mayer
Mar 1, 2005·The Annals of Thoracic Surgery·Frederick J Schoen, Robert J Levy
Jul 13, 2006·Annals of the New York Academy of Sciences·Sundeep Khosla, Guiti Z Eghbali-Fatourechi
Mar 24, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Cindy Ying Yin YipCraig A Simmons
May 6, 2009·Annual Review of Biomedical Engineering·Michael S SacksJohn E Mayer
Aug 29, 2009·Circulation Research·Michelle D Combs, Katherine E Yutzey
Feb 24, 2010·The Journal of Thoracic and Cardiovascular Surgery·Danielle GottliebJohn E Mayer
Sep 3, 2010·Annual Review of Physiology·Robert B Hinton, Katherine E Yutzey
Jul 25, 2012·Journal of Biomedical Materials Research. Part a·Nafiseh MasoumiGeorge C Engelmayr
Sep 6, 2012·ACS Applied Materials & Interfaces·Soumen JanaMiqin Zhang
Oct 24, 2012·Tissue Engineering. Part a·Zeeshan H SyedainRobert T Tranquillo
Feb 23, 2013·Critical Reviews in Immunology·Charles D Mills
Jun 19, 2013·Advanced Healthcare Materials·Forrest M KievitMiqin Zhang
Jul 31, 2013·Annals of Biomedical Engineering·Zeeshan H SyedainRobert T Tranquillo
Mar 29, 2014·Acta Biomaterialia·S JanaR D Simari
Apr 26, 2014·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Yasuhide NakayamaEisuke Tatsumi
Jun 21, 2014·Biomaterials·Nafiseh MasoumiAli Khademhosseini
Dec 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Soumen JanaAmir Lerman
Feb 26, 2015·Journal of Tissue Engineering and Regenerative Medicine·Soumen JanaAmir Lerman
Jun 2, 2015·Expert Opinion on Biological Therapy·Daniel Y CheungJonathan T Butcher
Aug 22, 2015·ACS Applied Materials & Interfaces·Soumen JanaRobert D Simari
Nov 20, 2016·Advanced Materials·Soumen JanaMiqin Zhang
Jan 26, 2018·The Journal of Thoracic and Cardiovascular Surgery·Ger BenninkRenu Virmani
May 28, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Soumen Jana, Miqin Zhang
Dec 21, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Matthew LeungMiqin Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

MetaMorph

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.